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Peripheral venous access is used for infusion of fluids, medications, and blood products. Penetration of these products through an intravenous (IV) access to surrounding 
tissues causes infiltration or extravasations injuries and accounts for 
23–78% of complications of peripheral IV (PIV) access [1]. Terms 
extravasations and infiltration are often used interchangeably; 
though extravasations occur as a result of endothelial damage 
due to the administration of vesicant medication while infiltration 
occurs with non-vesicant medication [2]. Typically, infiltration 
severity can range from Stage 1, where no swelling is present, 
to Stage 4 infiltrates that results in marked swelling, impaired 
circulation, skin breakdown, or necrosis [3]. Neonates are prone 
to infiltration due to their fragile vessels and a comparatively 
lesser amount of subcutaneous tissue [4]. Complications progress 
quickly from reduced tissue perfusion to tissue necrosis and even 
results in limb loss [3-8].
A survey of regional neonatal intensive care units (NICU) 
reported infiltration rate of 38/1000 babies which led to skin 
necrosis; most were due to PIVs [7]. The authors from Turkey 
reported the incidence of infiltration/extravasations in 45.6% of 
PIVs inserted into newborns; 9.7% were Stage I and 11.7% were 
Stage IV [9]. A study from India reports 86.6% cannulas (161 out 
of 186 cannulas) were infiltrated in 78 neonates [10]. Despite the 
potential for serious morbidity in the neonatal population, there 
are very few reports on the burden of PIV infiltration. Further, 
literature regarding interventions for reduction of infiltrates 
is meager [11-15]. Based on frequent observations of several 
cases of PIV infiltration, we conducted this study to find out the 
incidence rate of PIV infiltration in our NICU and reduce the rate 
through quality improvement (QI) methods.
METHODS
This was a QI initiative conducted in NICU of a tertiary care 
teaching hospital in Northern India, from March 2018 to June 
2018. The unit comprises 10 level III NICU beds, 10 step-
down beds, and 10 beds for babies in the maternity ward. All 
the admitted babies in NICU, who required PIV cannula, were 
included for collection of data after getting consent from the 
respective parents. Neonates with central lines or peripherally 
inserted central catheter (PICC) were excluded. Babies shifted to 
step down unit were also excluded as the chances of them having 
IV cannulas were low. The Institute Ethics Committee approved 
the study with a waiver of consent. The study was conducted in 
two phases, i.e., baseline phase of 4 weeks and the implementation 
phase over 12 weeks.
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In the baseline phase, data on the rate of PIV infiltrates were 
collected over a period of 4 weeks. This was done by voluntary 
reporting by nurses and doctors; counting a total number of 
inserted cannulas each day by proxy, with the help of cannula 
boxes, especially made for the collection of cannula covers of 
inserted cannulae; and nursing report book. The study objective 
was to decrease the baseline rate by at least 30% over the next 
12 weeks.
A team comprising one faculty doctor, one resident doctor and 
two nurses was formed. The team tried to find out possible reasons 
for PIV cannula infiltration in our unit using fishbone analysis 
(Fig. 1). The major barriers were: inadequate knowledge of 
insertion procedure and identification of early stages of infiltration; 
absence of a unit policy on steps; maintenance of PIV cannula; and 
overlooking of catheter sites by nurses due to busy shifts.
During the implementation phase, these factors were 
addressed using a series of Plan-Do-Study-Act (PDSA) cycles 
(Table 1). The nurses and resident doctors were educated in 
early identification, and preventive measures of PIV infiltrates, 
particularly early stage injuries, using PowerPoint presentations, 
visual aids, and bedside skill teaching. Handouts and posters 
of infiltration grading charts were provided. These include – 
avoidance of joint for insertion site; 2- hourly IV site inspection; 
checking patency before infusion; use of transparent dressing for 
fixation; use of small volume saline flush after each medication; 
and use of extension line followed by looping it and documenting 
the IV infiltration event. A comprehensive unit policy on PIV 
cannula insertion procedure and maintenance was made.
During clinical rounds each day, nurses were appreciated for 
their efforts on a one-to-one basis. Closed group social media 
platform was used for positive reinforcement and for reminders 
and messages for improving clinical practice. A combined 
meeting of all team members was conducted every fortnightly, 
to analyze the results and provide feedback to all the staffs. The 
primary outcome measure was the rate of PIV infiltration. This 
was calculated using the formula: Total no of reported infiltration 
×100/no of PIV days. The PIV days were calculated as a number 
of indwelling PIV cannulas each day for that month.
Descriptive statistics were used to describe baseline 
characteristics of the patient population. Data were analyzed 
using Microsoft Excel version 2011. Attribute u-charts were used 
to display and interpret the serial measurement of indicators and 
to study the impact of changes. This type of chart accounts for 
differing sample sizes over time in this study the number of line 
days per month [16]. Significant changes; were interpreted as per 
standard rules.
RESULTS
Demographic characteristics of the study population in the 
baseline and implementation phase were comparable (Table 2). 
The baseline incidence of infiltration was 60.8/100 IV line days. 
Table 1: PDSA cycles
No. Plan Do Study Act
1 Education of nurses and resident 
doctors about infiltration injury
Use of PowerPoint presentations, 
visual aids, bedside skill teaching
Infiltration rate decreased 
slightly (58.2/100 IV line days)
Infiltration record and grade charts 
put bedside to be filled in every shift
2 Unit policy on insertion 
technique and maintenance
Education and skill demonstration Infiltration rate decreased 
(33/100 IV line days)
Unit policy compliance check
3 Attitudinal change Appreciation, reminders, positive 
reinforcement
Infiltration rates decreased 
(21.4/100 IV line days)
Ongoing sensitization and positive 
reinforcement
PDSA: Plan‑Do‑Study‑Act
Figure 1: Fishbone analysis
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Following the implementation of interventions, there was a 
gradual decline in the infiltration rate from 60.8 to 21.4/100 IV 
line days (Fig. 2). This special cause event was related to rigorous 
implementation and performance monitoring of interventions 
in the PDSA cycles. The average duration of cannula before 
infiltration was 18.2 h during the baseline phase, which increased 
to 42.2 h by the end of 3 months (Table 3).
DISCUSSION
This QI effort was a stepwise introduction of measures to reduce 
PIV infiltration rate in our unit driven by PDSA cycles. There 
was a reduction in overall PIV infiltration rates by 64.8% from 
baseline at the end of the third PDSA cycle. Furthermore, there 
was an improvement in the average duration of cannula before 
infiltration.
The barriers, associated with PIV infiltration, found in the 
study were similar to other studies. Several studies have observed 
gaps in practices such as lack of knowledge about infiltration 
injury, inability to recognize the injury, lack of perceived priority 
to assess IV site for infiltration, and attitudinal problems such 
as resistance in accepting new practices [10,17-19]. Technical 
factors associated with infiltration include over-reliance on 
infusion pump alarms, infrequent checking of sites, type of 
medicines, and use of inappropriate dilutions. A study from 
India observed cefotaxime infusion as an important aggravating 
factor for infiltration [10]. A QI audit of nursing practices for 
PIV therapy found 52.2% of PIVs were infiltrated despite having 
NICU guidelines for insertion. Lower-extremity placements were 
associated with more frequent leakage and scalp placements with 
more occlusion [19].
Role of educational interventions in decreasing PIV infiltration 
cannot be overemphasized. Use of workshops, informative 
PowerPoint presentations, posters, laminated cards, online 
modules for assessment, and skill demonstration have reportedly 
decreased PIV infiltration in various studies [14,20-22]. Timely 
site assessment, restricting a number of attempts, early central 
access and formulation of unit policy or algorithm for PIV 
insertion and prevention have observed a reduction in infiltration 
injury [14,20-21,23]. In addition, the involvement of the family 
in identifying the infiltration injury has also been successful in 
one study [22]. Along with these interventions, we used a closed 
group social media platform for appreciation, reminders, and 
positive encouragement of NICU staff.
This study demonstrated a gradual decline in infiltration 
rates and improved duration of the cannula with unsophisticated 
existing measures. There was initial resistance to change in 
practice in our unit. Nevertheless, with consistent efforts along 
with positive reinforcement of staff, there was a decrease in PIV 
infiltration rate. There were a few limitations to this study; first, 
being a single-center study, the interventions implemented by 
us may not be a generalized factor (such as lack of resources or 
willingness to improvise the process) to other settings. Second, we 
have not studied the sustainability of the improvements achieved 
in the study unit over a long period. However, we will continue 
to monitor the compliance with this QI initiative to sustain the 
results.
Figure 2: U‑chart
Table 3: Monthwise record of infiltration injury
Variable 1st month 2nd month 3rd month 4th month
Average number 
of IV cannula 
inserted per day
4.8 3.9 2.9 1.9
Average infiltration 
ratea (per 100 IV 
line days)
60.8 (21.5) 58.2 (25.2) 33 (24.9) 21.4 (17.0)
Duration of 
cannula (hours) a
18.2 (10.1) 42.9 (23.1) 41.3 (21.9) 42.2 (24.2)
aValues are expressed in mean (SD). SD: Standard deviation
Table 2: Baseline characteristics of the population
Variable Pre‑implementation 
phase
Implementation 
phase
Total number of babies 29 77
Gestation age in weeksa 35.5 (33–38) 36 (32–37)
Birth weight in gramsa 1708 (2328–3075) 2200 (1300–2500)
Male gender n (%) 24 (82.7) 61 (79.2)
aValues are expressed in median (interquartile range)
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CONCLUSIONS
This QI study demonstrated that with available resources and 
simple measures, it is possible to improve the PIV infiltration 
rate. To sustain the improvement, we continue to use visual 
reminders, regular education, compliant to unit policy, and 
positive reinforcement.
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